Close Menu

NEW YORK (360Dx) – Metabolomics Technologies today said it has inked a multiyear, non-exclusive licensing and distribution deal with Evolution Laboratories for Metabolomics' pre-colorectal cancer test. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.